Hydrocortisone acetate and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Hydrocortisone acetate (hydrocortisone acetate), especially for people who are male, 10-19 old, also take Somavert, and have Growth hormone-producing pituitary tumor.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Hydrocortisone acetate. It is created by eHealthMe based on reports of 4,300 people who have side effects when taking Hydrocortisone acetate from the FDA, and is updated regularly.

What is Hydrocortisone acetate?

Hydrocortisone acetate has active ingredients of hydrocortisone acetate. It is often used in ulcerative colitis. eHealthMe is studying from 4,344 Hydrocortisone acetate users. Check the latest studies of Hydrocortisone acetate.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,069 drugs and 913 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

On Jul, 18, 2026

4,300 people reported to have side effects when taking Hydrocortisone acetate.
Among them, 14 people (0.33%) have Neoplasm progression.

Could Hydrocortisone acetate cause Neoplasm progression?

Among these 14 people:

What is the gender of people who have Neoplasm progression when taking Hydrocortisone acetate? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Neoplasm progression when taking Hydrocortisone acetate? *

What are other drugs people take besides Hydrocortisone acetate? *

Somavert: 11 people, 78.57%
Propranolol Hydrochloride: 10 people, 71.43%
Primidone: 10 people, 71.43%
Synthroid: 10 people, 71.43%
Atomoxetine: 10 people, 71.43%
Strattera: 10 people, 71.43%
Carbamazepine: 10 people, 71.43%
Risperidone: 10 people, 71.43%
Cortef: 10 people, 71.43%
Melatonin: 10 people, 71.43%

What are other side effects people have besides Neoplasm progression? *

Nausea (feeling of having an urge to vomit): 12 people, 85.71%
Nausea And Vomiting: 12 people, 85.71%
Viral Diarrhea: 10 people, 71.43%
Fever: 10 people, 71.43%
Hepatotoxicity (chemical-driven liver damage): 10 people, 71.43%
Hepatic Enzyme Increased: 10 people, 71.43%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 10 people, 71.43%
Head Injury: 10 people, 71.43%
Gastric Hypomotility (less movement of stomach): 10 people, 71.43%
Gait Disturbance: 10 people, 71.43%

What are the existing conditions these people have? *

Pituitary Tumor: 10 people, 71.43%
Growth Hormone-Producing Pituitary Tumor: 10 people, 71.43%
Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 64.29%
Constipation: 5 people, 35.71%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 14.29%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone acetate and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydrocortisone acetate:

Hydrocortisone acetate (4,344 reports)

Browse all side effects of Hydrocortisone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,069 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone acetate (the active ingredients of Hydrocortisone acetate) and Hydrocortisone acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.